Search Results

You are looking at 1 - 1 of 1 items for :

  • Author or Editor: Alison H. Robbins x
  • Veterinary Medicine Today x
  • Refine by Access: All Content x
Clear All Modify Search


To document the number of human contacts with bait containing liquid vaccinia-rabies glycoprotein (V-RG) vaccine, to evaluate factors that might affect human contact with bait-vaccine units, and to summarize adverse reactions in people after contact with vaccine.


Retrospective 4-year survey of directors of 6 oral rabies vaccination programs.

Sample Population

Human residents in areas of vaccination programs.


Data were collected from report forms and telephone conversations with directors of oral rabies vaccination programs in Florida, Massachusetts, New Jersey, Texas, and New York. Data collected included information regarding human contact with bait and vaccine, sex and age of person involved in contact, human population density, bait density, type of labeling used on bait, and other factors.


Human contact with bait was more likely in areas where bait had white labels (vs lettering in black ink) and in areas with high human population densities. Directors of all programs reported that human contact with bait-vaccine units was minimal. Adverse reactions in exposed people were not reported. On the basis of these findings, concerns about V-RG vaccine posing a substantial public health risk remain unfounded.

Clinical Implications

Directors of oral rabies vaccination programs should systematically collect information about exposures and potential factors affecting exposure of people to bait-vaccine units. People with substantial exposure to V-RG vaccine should be evaluated for immune status and any resulting symptoms should be documented and monitored. (J Am Vet Med Assoc 1998;213:1413-1417)

Free access
in Journal of the American Veterinary Medical Association